IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 240 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $80,473 | -99.4% | 10,034 | -97.5% | 0.00% | -100.0% |
| Q1 2021 | $12,616,000 | +376.4% | 398,484 | +598.2% | 0.01% | +300.0% |
| Q4 2020 | $2,648,000 | -26.9% | 57,075 | -48.1% | 0.00% | -25.0% |
| Q3 2020 | $3,624,000 | +38.9% | 110,075 | +15.8% | 0.00% | +33.3% |
| Q2 2020 | $2,610,000 | +148.3% | 95,075 | +170.9% | 0.00% | +50.0% |
| Q1 2020 | $1,051,000 | +11.0% | 35,100 | -52.6% | 0.00% | +100.0% |
| Q2 2018 | $947,000 | – | 74,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |